[Tickers Inside] 7 Solid Gainers Over the Last 5 Sessions

Stocks with 5 days of consecutive price advances. If you cannot see this email properly, please click [here]( [marketticker...] --------------------------------------------------------------- ["White Gold" is the New Oil]( [Read this free report before it gets the attention of Wall Street.]([aff_i?offer_...] --------------------------------------------------------------- October 5, 2022 From the desk of the Editor (5 Day Gainers Report) Dear Reader, We just identified 7 Five Day Gainers of all US Exchanges. If you are interested in any of these companies, we encourage you to do your own research and due diligence. Keep reading to see what we just uncovered... --------------------------------------------------------------- [The Lithium "Lie"]( [7fc9c7e5-b28...](Did you know each electric car battery requires 220 pounds of graphite ñ more than lithium, copper, or aluminum? China controls more than 90% of this vital ingredient. But the U.S. just classified graphite as "essential for America's National Defense"... and one little-known company is looking to win big in the energy war with China. [Find Out How Investors Can Benefit From the Energy War with China]( [5381a560-c43...]([aff_i?offer_...] --------------------------------------------------------------- [Immunovant, IMVT]( Recent Analyst Action: Douglas Tsao, analyst at H.C. Wainwright, reiterates coverage on [Immunovant (IMVT)](in the Healthcare sector with a Buy rating (6 days ago). - Recent Price: $9.145 - Average Analyst Price Target: $8.75 (-4.32%) - Market Cap: $952.44M [TipRanks.com]( also reports that [Immunovant](currently has 5 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $8.75. The target pricing ranges from a high forecast of $12.00 down to a low forecast of $5.00. [Immunovant (IMVT)](’s last closing price was $9.145 which would put the average price target at $8.75. Here are 3rd party ratings for [IMVT](: - TipRanks.com: Moderate Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 24% (61 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- [#1 Stock for Energy Crisis (Buy Now for Just $8)]( [50761ef9-9b9...](As the world suffers an oil shock… And gas prices rip higher… One tiny company could have the answer to the global energy crisis. It’s using AI to crack open the largest untapped energy source on the planet… 5X larger than the biggest oil field on Earth. [Act fast, this $8 stock could be moments away from appreciating considerably.]( [5381a560-c43...]( [aff_i?offer_...] --------------------------------------------------------------- [Circor International, CIR]( Recent Analyst Action: Nathan Jones, analyst at Stifel Nicolaus, reiterates coverage on [Circor International (CIR)](in the Industrial Goods sector with a Buy rating and a price target of $25.00 (2 days ago). - Recent Price: $19.26 - Average Analyst Price Target: $24.33 (26.32%) - Market Cap: $385.85M [TipRanks.com]( also reports that [Circor International](currently has 3 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $24.33. The target pricing ranges from a high forecast of $27.00 down to a low forecast of $21.00. [Circor International (CIR)](’s last closing price was $19.26 which would put the average price target at $24.33. Here are 3rd party ratings for [CIR](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Strong Sell, Bottom 18% (205 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- [IVERIC bio, ISEE]( Recent Analyst Action: Annabel Samimy, analyst at Stifel Nicolaus, reiterates coverage on [IVERIC bio (ISEE)](in the Healthcare sector with a Buy rating and a price target of $35.00 (3 weeks ago). - Recent Price: $21.21 - Average Analyst Price Target: $27.50 (29.66%) - Market Cap: $2.34B [TipRanks.com]( also reports that [IVERIC bio](currently has 10 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $27.50. The target pricing ranges from a high forecast of $35.00 down to a low forecast of $8.00. [IVERIC bio (ISEE)](’s last closing price was $21.21 which would put the average price target at $27.50. Here are 3rd party ratings for [ISEE](: - TipRanks.com: Strong Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Buy, Top 24% (61 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- [The Best Investing Tool You Can Buy for $1]( [fb1fe41e-747...](Gains as high as 834%... 1,315%...and 1,601% already uncovered... [Get instant access to this powerful tool for just $1!]( [5381a560-c43...]( [aff_i?offer_...] --------------------------------------------------------------- [NOV, NOV]( Recent Analyst Action: Marc Bianchi, analyst at Cowen & Co., reiterates coverage on [NOV (NOV)](in the Industrial Goods sector with a Buy rating and a price target of $21.00 (1 day ago). - Recent Price: $17.89 - Average Analyst Price Target: $21.13 (18.11%) - Market Cap: $6.90B [TipRanks.com]( also reports that [NOV](currently has 9 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $21.13. The target pricing ranges from a high forecast of $27.00 down to a low forecast of $16.00. [NOV (NOV)](’s last closing price was $17.89 which would put the average price target at $21.13. Here are 3rd party ratings for [NOV](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Strong Buy, Bottom 43% (144 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- [Now, DNOW]( Recent Analyst Action: Nathan Jones, analyst at Stifel Nicolaus, reiterates coverage on [Now (DNOW)](in the Industrial Goods sector with a Buy rating and a price target of $14.00 (2 months ago). - Recent Price: $11.53 - Average Analyst Price Target: $13.67 (18.56%) - Market Cap: $1.26B [TipRanks.com]( also reports that [Now](currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $13.67. The target pricing ranges from a high forecast of $14.00 down to a low forecast of $13.00. [Now (DNOW)](’s last closing price was $11.53 which would put the average price target at $13.67. Here are 3rd party ratings for [DNOW](: - TipRanks.com: Strong Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: buy - Zacks.com: Strong Buy, Top 11% (28 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- [Investors See Opportunity in Huge Global Demand for Lithium]( [e2eaf5b3-922...](The global lithium market is projected to surge 500% due to a growing need for lithium-filled batteries. And one junior mining company in a renowned location in South America is in the right place at the right time to capitalize on this megatrend. [Put this company on your investing radar today.]( [5381a560-c43...]( [aff_i?offer_...] --------------------------------------------------------------- [Transphorm, TGAN]( Recent Analyst Action: David Williams, analyst at Benchmark Co., reiterates coverage on [Transphorm (TGAN)](in the Technology sector with a Buy rating and a price target of $8.00 (1 month ago). - Recent Price: $5.4 - Average Analyst Price Target: $8.00 (48.15%) - Market Cap: $301.19M [TipRanks.com]( also reports that [Transphorm](currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $8.00. The target pricing ranges from a high forecast of $8.00 down to a low forecast of $8.00. [Transphorm (TGAN)](’s last closing price was $5.4 which would put the average price target at $8.00. Here are 3rd party ratings for [TGAN](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: sell - Zacks.com: Sell, Bottom 36% (160 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- [SCYNEXIS, SCYX]( Recent Analyst Action: Michael Higgins, analyst at Ladenburg Thalmann & Co., reiterates coverage on [SCYNEXIS (SCYX)](in the Healthcare sector with a Buy rating and a price target of $15.00 (1 month ago). - Recent Price: $2.53 - Average Analyst Price Target: $11.33 (347.83%) - Market Cap: $83.26M [TipRanks.com]( also reports that [SCYNEXIS](currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $11.33. The target pricing ranges from a high forecast of $15.00 down to a low forecast of $8.00. [SCYNEXIS (SCYX)](’s last closing price was $2.53 which would put the average price target at $11.33. Here are 3rd party ratings for [SCYX](: - TipRanks.com: Strong Buy - TradingView.com: Neutral - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: sell - Zacks.com: Hold, Top 30% (75 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- [GRAPHITE: "Essential for America's National Defense"]( [28723724-9dc...](Did you know each EV battery contains up to 220 pounds of graphite and China controls more than 90% of the world's graphite trade? But now that the U.S. has classified it as "essential for America's National Defense"... one little-known company could become America's ONLY fully integrated graphite provider. [Discover Who's Poised to Benefit In The U.S. vs. China Energy War]( [5381a560-c43...]([aff_i?offer_...] --------------------------------------------------------------- And there you have it--7 Five Day Gainers of all US Exchanges. Sincerely, The Editor, MarketTickerPress.com Market Ticker Press Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. By opening and/or clicking a link containted within this email, you are reconfirming your opt-in status. You can unsubscribe at any time. MarketTickerPress.com part of Sandpiper Marketing Group | 1519 Mecklenburg Hwy | Unit 4 | Mt. Mourne | North Carolina | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software